Canada Life’s Puma Biotechnology PBYI Stock Holding History

Canada Life’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,002	Closed	-$14K	–	2539
2021 Q3	$14K	Hold	2,002	–	–	﹤0.01%	2482
2021 Q2	$18K	Hold	2,002	–	–	﹤0.01%	2501
2021 Q1	$19K	Hold	2,002	–	–	﹤0.01%	2516
2020 Q4	$20K	Hold	2,002	–	–	﹤0.01%	2539
2020 Q3	$20K	Hold	2,002	–	–	﹤0.01%	2444
2020 Q2	$21K	Hold	2,002	–	–	﹤0.01%	2487
2020 Q1	$17K	Hold	2,002	–	–	﹤0.01%	2411
2019 Q4	$17K	Buy	+2,002	New	+$16.6K	﹤0.01%	2533
2019 Q3	–	Sell	-3,774	Closed	-$48K	–	1934
2019 Q2	$48K	Hold	3,774	–	–	﹤0.01%	2451
2019 Q1	$146K	Hold	3,774	–	–	﹤0.01%	1955
2018 Q4	$74K	Hold	3,774	–	–	﹤0.01%	2244
2018 Q3	$173K	Hold	3,774	–	–	﹤0.01%	2030
2018 Q2	$223K	Hold	3,774	–	–	﹤0.01%	1947
2018 Q1	$257K	Hold	3,774	–	–	﹤0.01%	1889
2017 Q4	$372K	Buy	3,774 +765	+25%	+$85.6K	﹤0.01%	1806
2017 Q3	$352K	Hold	3,009	–	–	﹤0.01%	1803
2017 Q2	$262K	Hold	3,009	–	–	﹤0.01%	1857
2017 Q1	$112K	Hold	3,009	–	–	﹤0.01%	2084
2016 Q4	$93K	Hold	3,009	–	–	﹤0.01%	2137
2016 Q3	$201K	Hold	3,009	–	–	﹤0.01%	1906
2016 Q2	$89K	Hold	3,009	–	–	﹤0.01%	2144
2016 Q1	$88K	Hold	3,009	–	–	﹤0.01%	1872
2015 Q4	$236K	Sell	3,009 -2,719	-47%	-$213K	﹤0.01%	1200
2015 Q3	$432K	Buy	5,728 +2,076	+57%	+$196K	﹤0.01%	923
2015 Q2	$425K	Buy	3,652 +1,564	+75%	+$283K	﹤0.01%	1053
2015 Q1	$491K	Hold	2,088	–	–	﹤0.01%	988
2014 Q4	$394K	Hold	2,088	–	–	﹤0.01%	1011
2014 Q3	$500K	Buy	2,088 +316	+18%	+$64.9K	﹤0.01%	948
2014 Q2	$117K	Buy	+1,772	New	+$126K	﹤0.01%	1472

Other funds holding PBYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Canada Life's PBYI Position: Q4 2021 in Review

Canada Life sold out of Puma Biotechnology (PBYI) in Q4 2021, closing a stake of 2,002 shares — an estimated $14K sold.

Canada Life first reported a position in PBYI in Q2 2014 and held it in 29 quarters. The position peaked at $500K in Q3 2014. 102 funds tracked by Wall St. Rank hold PBYI as of Q4 2021.

Canada Life reported no remaining Puma Biotechnology position as of Q4 2021 after selling out during the quarter.
Canada Life sold 2,002 Puma Biotechnology shares in Q4 2021, an estimated $14K.
Canada Life first reported a position in Puma Biotechnology in Q2 2014 and held it in 29 quarters.
Canada Life's Puma Biotechnology position peaked at $500K in Q3 2014.
102 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.